Bulk Tirzepatide Pens for Laboratory Research - Pharmaceutical Grade

Tirzepatide pens contain a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist compound. This pharmaceutical grade material (CAS 2023788-19-2) demonstrates superior efficacy in glucose control and weight management compared to single receptor agonists.

The tirzepatide pens formulation exhibits preferential binding affinity for GIP receptors while maintaining significant GLP-1 receptor activity. This unique dual mechanism has shown enhanced hyperglycemia reduction in clinical research settings compared to selective GLP-1 receptor agonists.

Our tirzepatide pens are supplied as white lyophilized powder in sterile vials with rubber stoppers and aluminum seals. The compound has demonstrated neuroprotective properties in preclinical studies, suggesting potential applications beyond metabolic disorder research.

Available in multiple concentrations from 5mg to 60mg per vial, our tirzepatide pens can be customized with specific packaging configurations including various vial sizes and box quantities. All batches undergo rigorous quality control testing including HPLC purity verification.

Note: This product is intended for research purposes only. Not for human consumption or diagnostic use. Proper laboratory handling procedures should be followed when working with this compound.